Ngā hua rapu - Jeong‐A Lim
- E whakaatu ana i te 1 - 12 hua o te 12
-
1
Pompe disease: from pathophysiology to therapy and back again mā Jeong‐A Lim, Lishu Li, Nina Raben
I whakaputaina 2014Revisão -
2
Therapeutic Benefit of Autophagy Modulation in Pompe Disease mā Jeong‐A Lim, Baodong Sun, Rosa Puertollano, Nina Raben
I whakaputaina 2018Artigo -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease mā Carmine Spampanato, Erin Feeney, Lishu Li, Monica Cardone, Jeong‐A Lim, Fabio Annunziata, Hossein Zare, Roman Polishchuk, Rosa Puertollano, Giancarlo Parenti, Andrea Ballabio, Nina Raben
I whakaputaina 2013Artigo -
11
TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophages mā Nunzia Pastore, Owen A. Brady, Heba I. Diab, José A. Martina, Lu Sun, Tuong Huynh, Jeong‐A Lim, Hossein Zare, Nina Raben, Andrea Ballabio, Rosa Puertollano
I whakaputaina 2016Artigo -
12
Anti-Tumoral Effect of the Mitochondrial Target Domain of Noxa Delivered by an Engineered Salmonella typhimurium mā Jae‐Ho Jeong, Kwangsoo Kim, Daejin Lim, Kwangjoon Jeong, Yeongjin Hong, Vu H. Nguyen, Tae‐Hyoung Kim, Sangryeol Ryu, Jeong-A Lim, Jae Il Kim, Geun‐Joong Kim, Sun Chang Kim, Jung‐Joon Min, Hyon E. Choy
I whakaputaina 2014Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Gene
Biochemistry
Cell biology
Apoptosis
Autophagy
Medicine
Disease
Genetics
Endocrinology
Internal medicine
Skeletal muscle
TFEB
Transcription factor
ATG16L1
Bacteria
Basic helix-loop-helix leucine zipper transcription factors
Computer science
DNA-binding protein
Downregulation and upregulation
Enzyme
Enzyme replacement therapy
Glycogen
Glycogen storage disease type II
Microbiology
Neuroscience
Pathology
Adeno-associated virus
Atrophy
Bacterial outer membrane